Waiting times for systemic cancer therapy in the United Kingdom in 2006 View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-08-26

AUTHORS

M V Williams, K J Drinkwater, A Jones, B O'Sullivan, D Tait

ABSTRACT

This audit was conducted to measure waiting times for systemic cancer therapy across the United Kingdom. All patients, aged 16 years or older, commencing their first course of systemic therapy between 13 November and 19 November 2006 were eligible for inclusion. Data on 936 patients from 81 hospital sources were collected. Systemic therapy is largely given in compliance with national waiting time targets. In terms of the Joint Council for Clinical Oncology (JCCO) targets, 84% of patients commence treatment within 21 days and 98% of patients complied with the Department of Health target that treatment should follow within 31 days of the decision being agreed with the patient. Only 76% complied with the Department of Health 62-day target from GP referral to first definitive treatment. However, the date of urgent referral by the GP was not submitted for most patients in our survey, leaving a sample of only 84 out of 936 patients (9% of total) suitable for this analysis. There was only a 3- to 5-day difference between the waiting times for systemic therapy for patients categorised as urgent compared with routine. Locally agreed definitions had little impact on patients' priority for treatment. This audit has established a baseline measurement of waiting times for systemic therapy across the United Kingdom. The continuing introduction of novel therapies is likely to have a significant effect on the service and we recommend that service managers model the likely impact on resource requirements. In addition, urgent treatment should be clearly defined as that required within 24 h (maximum 48 h) to avoid the risk of clinical deterioration, particularly in patients with acute leukaemia, lymphoma or germ cell tumour. More... »

PAGES

695-703

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6604529

DOI

http://dx.doi.org/10.1038/sj.bjc.6604529

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1018550629

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18728658


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medical Audit", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Compliance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Referral and Consultation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "State Medicine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United Kingdom", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Waiting Lists", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Oncology Centre, Box 193, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Hills Road, CB2 0QQ, Cambridge, UK", 
          "id": "http://www.grid.ac/institutes/grid.120073.7", 
          "name": [
            "The Royal College of Radiologists, 38 Portland Place, W1B 1JQ, London, UK", 
            "Oncology Centre, Box 193, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Hills Road, CB2 0QQ, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Williams", 
        "givenName": "M V", 
        "id": "sg:person.0761533456.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761533456.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Royal College of Radiologists, 38 Portland Place, W1B 1JQ, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.464682.a", 
          "name": [
            "The Royal College of Radiologists, 38 Portland Place, W1B 1JQ, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Drinkwater", 
        "givenName": "K J", 
        "id": "sg:person.0612344556.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612344556.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Oncology Department, The Royal Free Hospital, Pond Street, LondonNW3 2QG, UK", 
          "id": "http://www.grid.ac/institutes/grid.426108.9", 
          "name": [
            "The Royal College of Physicians, 11 St Andrews Place, Regent's Park, NW1 4LE, London, UK", 
            "Medical Oncology Department, The Royal Free Hospital, Pond Street, LondonNW3 2QG, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jones", 
        "givenName": "A", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oncology Centre, Box 193, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Hills Road, CB2 0QQ, Cambridge, UK", 
          "id": "http://www.grid.ac/institutes/grid.120073.7", 
          "name": [
            "Oncology Centre, Box 193, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Hills Road, CB2 0QQ, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "O'Sullivan", 
        "givenName": "B", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Oncology, The Royal Marsden NHS Foundation Trust, Downs Road, SM2 5PT, Sutton, Surrey, UK", 
          "id": "http://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Department of Clinical Oncology, The Royal Marsden NHS Foundation Trust, Downs Road, SM2 5PT, Sutton, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tait", 
        "givenName": "D", 
        "id": "sg:person.0753037103.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753037103.30"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6601149", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010666279", 
          "https://doi.org/10.1038/sj.bjc.6601149"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-006-9206-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001714469", 
          "https://doi.org/10.1007/s10549-006-9206-z"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-08-26", 
    "datePublishedReg": "2008-08-26", 
    "description": "This audit was conducted to measure waiting times for systemic cancer therapy across the United Kingdom. All patients, aged 16 years or older, commencing their first course of systemic therapy between 13 November and 19 November 2006 were eligible for inclusion. Data on 936 patients from 81 hospital sources were collected. Systemic therapy is largely given in compliance with national waiting time targets. In terms of the Joint Council for Clinical Oncology (JCCO) targets, 84% of patients commence treatment within 21 days and 98% of patients complied with the Department of Health target that treatment should follow within 31 days of the decision being agreed with the patient. Only 76% complied with the Department of Health 62-day target from GP referral to first definitive treatment. However, the date of urgent referral by the GP was not submitted for most patients in our survey, leaving a sample of only 84 out of 936 patients (9% of total) suitable for this analysis. There was only a 3- to 5-day difference between the waiting times for systemic therapy for patients categorised as urgent compared with routine. Locally agreed definitions had little impact on patients' priority for treatment. This audit has established a baseline measurement of waiting times for systemic therapy across the United Kingdom. The continuing introduction of novel therapies is likely to have a significant effect on the service and we recommend that service managers model the likely impact on resource requirements. In addition, urgent treatment should be clearly defined as that required within 24\u2009h (maximum 48\u2009h) to avoid the risk of clinical deterioration, particularly in patients with acute leukaemia, lymphoma or germ cell tumour.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bjc.6604529", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "99"
      }
    ], 
    "keywords": [
      "systemic therapy", 
      "systemic cancer therapy", 
      "first definitive treatment", 
      "germ cell tumors", 
      "cancer therapy", 
      "Department of Health", 
      "clinical deterioration", 
      "most patients", 
      "commence treatment", 
      "definitive treatment", 
      "GP referral", 
      "urgent referral", 
      "urgent treatment", 
      "acute leukemia", 
      "cell tumors", 
      "novel therapies", 
      "patient priorities", 
      "patients", 
      "hospital sources", 
      "health targets", 
      "therapy", 
      "baseline measurements", 
      "treatment", 
      "first course", 
      "referral", 
      "United Kingdom", 
      "days", 
      "Department", 
      "target", 
      "oncology target", 
      "audit", 
      "lymphoma", 
      "Joint Council", 
      "leukemia", 
      "tumors", 
      "time targets", 
      "significant effect", 
      "service managers", 
      "risk", 
      "health", 
      "GPs", 
      "compliance", 
      "years", 
      "course", 
      "deterioration", 
      "time", 
      "little impact", 
      "differences", 
      "Kingdom", 
      "impact", 
      "priority", 
      "date", 
      "effect", 
      "survey", 
      "likely impact", 
      "samples", 
      "inclusion", 
      "data", 
      "addition", 
      "routines", 
      "services", 
      "analysis", 
      "definition", 
      "introduction", 
      "decisions", 
      "measurements", 
      "Council", 
      "terms", 
      "source", 
      "requirements", 
      "resource requirements", 
      "managers"
    ], 
    "name": "Waiting times for systemic cancer therapy in the United Kingdom in 2006", 
    "pagination": "695-703", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1018550629"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6604529"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18728658"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6604529", 
      "https://app.dimensions.ai/details/publication/pub.1018550629"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:34", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_466.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bjc.6604529"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604529'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604529'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604529'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604529'


 

This table displays all metadata directly associated to this object as RDF triples.

222 TRIPLES      21 PREDICATES      110 URIs      100 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6604529 schema:about N03fd0c8db1e747c3a774861a3f0f273d
2 N1495df96c20b449da1c75433a55bb445
3 N2b36d022d2884856a69c217430aac38b
4 N3948f0c8f5ca409a97b86e11b06478a9
5 N68c3cfe3c8bf4073b9c2382eefb78282
6 N71d606a219864066a8fd190534cd6226
7 N99379009c46b4134b6140606995230a9
8 Nd20711e1b177422e8073295ec20dc329
9 Ndd2ed29ed9c44cb7970e1f5748523fa7
10 Nee19d4552cbb42d79be46847f9b27085
11 Nfc8f473600304e3ea120c04bed8be544
12 anzsrc-for:11
13 anzsrc-for:1112
14 schema:author N0d92f9d3b0fb491aa46f1d84d367fd97
15 schema:citation sg:pub.10.1007/s10549-006-9206-z
16 sg:pub.10.1038/sj.bjc.6601149
17 schema:datePublished 2008-08-26
18 schema:datePublishedReg 2008-08-26
19 schema:description This audit was conducted to measure waiting times for systemic cancer therapy across the United Kingdom. All patients, aged 16 years or older, commencing their first course of systemic therapy between 13 November and 19 November 2006 were eligible for inclusion. Data on 936 patients from 81 hospital sources were collected. Systemic therapy is largely given in compliance with national waiting time targets. In terms of the Joint Council for Clinical Oncology (JCCO) targets, 84% of patients commence treatment within 21 days and 98% of patients complied with the Department of Health target that treatment should follow within 31 days of the decision being agreed with the patient. Only 76% complied with the Department of Health 62-day target from GP referral to first definitive treatment. However, the date of urgent referral by the GP was not submitted for most patients in our survey, leaving a sample of only 84 out of 936 patients (9% of total) suitable for this analysis. There was only a 3- to 5-day difference between the waiting times for systemic therapy for patients categorised as urgent compared with routine. Locally agreed definitions had little impact on patients' priority for treatment. This audit has established a baseline measurement of waiting times for systemic therapy across the United Kingdom. The continuing introduction of novel therapies is likely to have a significant effect on the service and we recommend that service managers model the likely impact on resource requirements. In addition, urgent treatment should be clearly defined as that required within 24 h (maximum 48 h) to avoid the risk of clinical deterioration, particularly in patients with acute leukaemia, lymphoma or germ cell tumour.
20 schema:genre article
21 schema:isAccessibleForFree true
22 schema:isPartOf Ne6f6125755324dff953c3abfed255420
23 Nffbe1ea119004db9b1c071241fbcc775
24 sg:journal.1017082
25 schema:keywords Council
26 Department
27 Department of Health
28 GP referral
29 GPs
30 Joint Council
31 Kingdom
32 United Kingdom
33 acute leukemia
34 addition
35 analysis
36 audit
37 baseline measurements
38 cancer therapy
39 cell tumors
40 clinical deterioration
41 commence treatment
42 compliance
43 course
44 data
45 date
46 days
47 decisions
48 definition
49 definitive treatment
50 deterioration
51 differences
52 effect
53 first course
54 first definitive treatment
55 germ cell tumors
56 health
57 health targets
58 hospital sources
59 impact
60 inclusion
61 introduction
62 leukemia
63 likely impact
64 little impact
65 lymphoma
66 managers
67 measurements
68 most patients
69 novel therapies
70 oncology target
71 patient priorities
72 patients
73 priority
74 referral
75 requirements
76 resource requirements
77 risk
78 routines
79 samples
80 service managers
81 services
82 significant effect
83 source
84 survey
85 systemic cancer therapy
86 systemic therapy
87 target
88 terms
89 therapy
90 time
91 time targets
92 treatment
93 tumors
94 urgent referral
95 urgent treatment
96 years
97 schema:name Waiting times for systemic cancer therapy in the United Kingdom in 2006
98 schema:pagination 695-703
99 schema:productId N4cb9efadfcaa463c997292e61be9175e
100 N5ae17e4059564def8edf882e90c9d6cd
101 Na1c58a8b5506499db7fe5298b0bf5da0
102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018550629
103 https://doi.org/10.1038/sj.bjc.6604529
104 schema:sdDatePublished 2022-10-01T06:34
105 schema:sdLicense https://scigraph.springernature.com/explorer/license/
106 schema:sdPublisher Necf54a7449724eed8d186fb816d7b717
107 schema:url https://doi.org/10.1038/sj.bjc.6604529
108 sgo:license sg:explorer/license/
109 sgo:sdDataset articles
110 rdf:type schema:ScholarlyArticle
111 N03fd0c8db1e747c3a774861a3f0f273d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Neoplasms
113 rdf:type schema:DefinedTerm
114 N0b269919888d462d8de421f8cbfe5099 rdf:first Nc80f5b48b8824f7b8e13f1651d02a845
115 rdf:rest Na5c167b14c2f493ab0706443b8d59b99
116 N0d92f9d3b0fb491aa46f1d84d367fd97 rdf:first sg:person.0761533456.52
117 rdf:rest N6d8991b5bb70418da4e51fb911d14b31
118 N1495df96c20b449da1c75433a55bb445 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Antineoplastic Agents
120 rdf:type schema:DefinedTerm
121 N2b36d022d2884856a69c217430aac38b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name State Medicine
123 rdf:type schema:DefinedTerm
124 N3948f0c8f5ca409a97b86e11b06478a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Medical Audit
126 rdf:type schema:DefinedTerm
127 N4cb9efadfcaa463c997292e61be9175e schema:name pubmed_id
128 schema:value 18728658
129 rdf:type schema:PropertyValue
130 N4eabfb16b72543cdad15f337d29155ce schema:affiliation grid-institutes:grid.120073.7
131 schema:familyName O'Sullivan
132 schema:givenName B
133 rdf:type schema:Person
134 N5ae17e4059564def8edf882e90c9d6cd schema:name doi
135 schema:value 10.1038/sj.bjc.6604529
136 rdf:type schema:PropertyValue
137 N68c3cfe3c8bf4073b9c2382eefb78282 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Adolescent
139 rdf:type schema:DefinedTerm
140 N6d8991b5bb70418da4e51fb911d14b31 rdf:first sg:person.0612344556.37
141 rdf:rest N0b269919888d462d8de421f8cbfe5099
142 N71d606a219864066a8fd190534cd6226 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Patient Compliance
144 rdf:type schema:DefinedTerm
145 N7e9edf5265b744be891a73f3c671d3ad rdf:first sg:person.0753037103.30
146 rdf:rest rdf:nil
147 N99379009c46b4134b6140606995230a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Humans
149 rdf:type schema:DefinedTerm
150 Na1c58a8b5506499db7fe5298b0bf5da0 schema:name dimensions_id
151 schema:value pub.1018550629
152 rdf:type schema:PropertyValue
153 Na5c167b14c2f493ab0706443b8d59b99 rdf:first N4eabfb16b72543cdad15f337d29155ce
154 rdf:rest N7e9edf5265b744be891a73f3c671d3ad
155 Nc80f5b48b8824f7b8e13f1651d02a845 schema:affiliation grid-institutes:grid.426108.9
156 schema:familyName Jones
157 schema:givenName A
158 rdf:type schema:Person
159 Nd20711e1b177422e8073295ec20dc329 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Adult
161 rdf:type schema:DefinedTerm
162 Ndd2ed29ed9c44cb7970e1f5748523fa7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name United Kingdom
164 rdf:type schema:DefinedTerm
165 Ne6f6125755324dff953c3abfed255420 schema:volumeNumber 99
166 rdf:type schema:PublicationVolume
167 Necf54a7449724eed8d186fb816d7b717 schema:name Springer Nature - SN SciGraph project
168 rdf:type schema:Organization
169 Nee19d4552cbb42d79be46847f9b27085 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Waiting Lists
171 rdf:type schema:DefinedTerm
172 Nfc8f473600304e3ea120c04bed8be544 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Referral and Consultation
174 rdf:type schema:DefinedTerm
175 Nffbe1ea119004db9b1c071241fbcc775 schema:issueNumber 5
176 rdf:type schema:PublicationIssue
177 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
178 schema:name Medical and Health Sciences
179 rdf:type schema:DefinedTerm
180 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
181 schema:name Oncology and Carcinogenesis
182 rdf:type schema:DefinedTerm
183 sg:journal.1017082 schema:issn 0007-0920
184 1532-1827
185 schema:name British Journal of Cancer
186 schema:publisher Springer Nature
187 rdf:type schema:Periodical
188 sg:person.0612344556.37 schema:affiliation grid-institutes:grid.464682.a
189 schema:familyName Drinkwater
190 schema:givenName K J
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612344556.37
192 rdf:type schema:Person
193 sg:person.0753037103.30 schema:affiliation grid-institutes:grid.5072.0
194 schema:familyName Tait
195 schema:givenName D
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753037103.30
197 rdf:type schema:Person
198 sg:person.0761533456.52 schema:affiliation grid-institutes:grid.120073.7
199 schema:familyName Williams
200 schema:givenName M V
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761533456.52
202 rdf:type schema:Person
203 sg:pub.10.1007/s10549-006-9206-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1001714469
204 https://doi.org/10.1007/s10549-006-9206-z
205 rdf:type schema:CreativeWork
206 sg:pub.10.1038/sj.bjc.6601149 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010666279
207 https://doi.org/10.1038/sj.bjc.6601149
208 rdf:type schema:CreativeWork
209 grid-institutes:grid.120073.7 schema:alternateName Oncology Centre, Box 193, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Hills Road, CB2 0QQ, Cambridge, UK
210 schema:name Oncology Centre, Box 193, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Hills Road, CB2 0QQ, Cambridge, UK
211 The Royal College of Radiologists, 38 Portland Place, W1B 1JQ, London, UK
212 rdf:type schema:Organization
213 grid-institutes:grid.426108.9 schema:alternateName Medical Oncology Department, The Royal Free Hospital, Pond Street, LondonNW3 2QG, UK
214 schema:name Medical Oncology Department, The Royal Free Hospital, Pond Street, LondonNW3 2QG, UK
215 The Royal College of Physicians, 11 St Andrews Place, Regent's Park, NW1 4LE, London, UK
216 rdf:type schema:Organization
217 grid-institutes:grid.464682.a schema:alternateName The Royal College of Radiologists, 38 Portland Place, W1B 1JQ, London, UK
218 schema:name The Royal College of Radiologists, 38 Portland Place, W1B 1JQ, London, UK
219 rdf:type schema:Organization
220 grid-institutes:grid.5072.0 schema:alternateName Department of Clinical Oncology, The Royal Marsden NHS Foundation Trust, Downs Road, SM2 5PT, Sutton, Surrey, UK
221 schema:name Department of Clinical Oncology, The Royal Marsden NHS Foundation Trust, Downs Road, SM2 5PT, Sutton, Surrey, UK
222 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...